Harnessing tumor immune checkpoints for autoimmune disease therapeutics. [PDF]
Yang H, Zhang P, Wu Y, Xie N, Shen G.
europepmc +1 more source
Exploratory analysis of early changes in peripheral immune cell proportions and clinical response following methotrexate and biologic treatment in rheumatoid arthritis. [PDF]
Muraoka S +8 more
europepmc +1 more source
Impact of biologic and targeted synthetic therapies on bone health in immune-mediated inflammatory diseases: a narrative review. [PDF]
de la Cámara-Fernández I +5 more
europepmc +1 more source
Research advances in Janus kinase inhibitors for immune checkpoint inhibitors-related myocarditis. [PDF]
Leng J, Wang C, Bai C.
europepmc +1 more source
CD80 as an Important Immune Mediator and Therapeutic Target in Atherosclerosis. [PDF]
Blagov A +3 more
europepmc +1 more source
Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis. [PDF]
Finckh A +14 more
europepmc +1 more source
C-Peptide Provides Critical Contextual Insight Into Elevated Glucose Values During Progression to Type 1 Diabetes. [PDF]
Sims EK +7 more
europepmc +1 more source
Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review. [PDF]
Morad TT +5 more
europepmc +1 more source
The role and function of CTLA-4 in Sjögren's syndrome. [PDF]
Wen J, Zhang L, Xie L, Zhou D, Chen M.
europepmc +1 more source
CDAI trajectories in patients with rheumatoid arthritis treated with abatacept in real-world. [PDF]
Pope JE +7 more
europepmc +1 more source

